Organogenesis Holdings Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary: Organogenesis Holdings Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q2 2024.
Organogenesis Holdings Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$648K, a 14.5% decline year-over-year.
Organogenesis Holdings Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$2.08M, a 20.7% decline year-over-year.
Organogenesis Holdings Inc. annual Nonoperating Income (Expense) for 2023 was -$2.13M, a 5.49% decline from 2022.
Organogenesis Holdings Inc. annual Nonoperating Income (Expense) for 2022 was -$2.02M, a 77.9% increase from 2021.
Organogenesis Holdings Inc. annual Nonoperating Income (Expense) for 2021 was -$9.13M, a 2.19% decline from 2020.

Nonoperating Income (Expense), Trailing 12 Months (USD)

Nonoperating Income (Expense), Quarterly (USD)

Nonoperating Income (Expense), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$2.08M	-$648K	-$82K	-14.5%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	-$2M	-$491K	+$135K	+21.6%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$2.13M	-$528K	-$564K	-1567%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-29
Q3 2023	-$1.57M	-$413K	+$154K	+27.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	-$1.72M	-$566K	+$185K	+24.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	-$1.91M	-$626K	+$114K	+15.4%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$2.02M	$36K	+$898K		Oct 1, 2022	Dec 31, 2022	10-K	2024-02-29
Q3 2022	-$2.92M	-$567K	+$2.82M	+83.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$5.74M	-$751K	+$1.66M	+68.9%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	-$7.4M	-$740K	+$1.73M	+70.1%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-10
Q4 2021	-$9.13M	-$862K	+$2.02M	+70.1%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-29
Q3 2021	-$11.2M	-$3.38M	-$1.41M	-71.4%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021	-$9.74M	-$2.41M	+$474K	+16.4%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	-$10.2M	-$2.47M	-$1.28M	-107%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	-$8.94M	-$2.88M	-$2.42M	-524%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-01
Q3 2020	-$6.52M	-$1.97M	+$454K	+18.7%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-09
Q2 2020	-$6.97M	-$2.89M	-$580K	-25.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	-$6.39M	-$1.19M	+$2.31M	+66%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q4 2019	-$8.71M	-$462K	+$4.31M	+90.3%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-01
Q3 2019	-$13M	-$2.43M	+$553K	+18.6%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	-$13.6M	-$2.31M	+$651K	+22%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	-$14.2M	-$3.51M	-$1.03M	-41.5%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q4 2018	-$13.2M	-$4.77M	-$2.51M	-111%	Oct 1, 2018	Dec 31, 2018	10-K	2019-03-18
Q3 2018	-$10.7M	-$2.98M	-$241K	-8.8%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	-$10.4M	-$2.96M	-$338K	-12.9%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-09
Q1 2018	-$10.1M	-$2.48M	-$1.04M	-72.5%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q4 2017	-$9.06M	-$2.26M			Oct 1, 2017	Dec 31, 2017	10-K	2019-03-18
Q3 2017		-$2.74M			Jul 1, 2017	Sep 30, 2017	10-K	2019-03-18
Q2 2017		-$2.62M			Apr 1, 2017	Jun 30, 2017	10-K	2019-03-18
Q1 2017		-$1.44M			Jan 1, 2017	Mar 31, 2017	10-K	2019-03-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.